Возрастающая роль хирургии в мультимодальном лечении рака: комплексный обзор
https://doi.org/10.17650/2949-5857-2024-14-4-55-62
Аннотация
Схема лечения рака претерпела существенные изменения благодаря интеграции мультимодальных подходов, в которых ключевую роль играет хирургия. В настоящем подробном обзоре исследуется динамическая роль хирургических вмешательств в рамках многомодальной терапии рака, представлены исторические достижения, инновационные хирургические методы и их синергетические эффекты с другими методами лечения.
Особое внимание уделяется предоперационным, интраоперационным, и послеоперационным аспектам: выбору пациента, технологическим инновациям и мультидисциплинарному сотрудничеству. На примере анализа клинических случаев и клинических исследований проиллюстрирована эффективность хирургического вмешательства, а также проблемы сочетания хирургии с химиотерапией, лучевой терапией и новыми методами лечения. В обзоре рассмотрены спорные вопросы и будущие тенденции, подчеркивается необходимость персонализированной и точной медицины для улучшения результатов лечения пациентов. представленные идеи помогут клиницистам и исследователям оптимизировать хирургические стратегии в условиях обширного поля онкологической помощи.
Список литературы
1. Carrieri F.A., Smack C., Siddiqui I. et al. Tumor Treating fields: at the crossroads between physics and biology for cancer treatment. Front Oncol 2020;10. https://doi.org/10.3389/fonc.2020.575992
2. Fain S.N. Use of a mechanical suturing apparatus in low colorectal anastomosis. Arch Surg 1975;110(9):1079. https://doi.org/10.1001/archsurg.1975.01360150023004
3. Chang S.S., Bochner B.H., Chou R. et al. Treatment of NonMetastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/ SUO Guideline. J Urol 2017;198(3):552–9. https://doi.org/10.1016/j.juro.2017.04.086
4. Newman L., Fejerman L., Pal T. et al. Breast cancer disparities through the lens of the COVID-19 pandemic. Curr Breast Cancer Rep 2021;13(3):110–2. https://doi.org/10.1007/s12609-021-00419-x
5. Hashimoto N., Rabo C.S., Okita Y. et al. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 2012;116(3):574–80. https://doi.org/10.3171/2011.11.JNS11999
6. Walsh M.T., Couldwell W.T. Management options for cavernous sinus meningiomas. J Neuro-Oncol 2009;92(3):307–16. https://doi.org/10.1007/s11060-009-9824-5
7. Vernooij M.W., Ikram M.A., Tanghe H.L. et al. Incidental findings on brain mri in the general population. N Engl J Med 2007;357(18):1821–8. https://doi.org/10.1056/nejmoa070972
8. Umansky F., Nathan H. The lateral wall of the cavernous sinus. With special reference to the nerves related to it. J Neurosurg 1982;56(2):228–34. https://doi.org/10.3171/jns.1982.56.2.0228
9. Chamoun R., Krisht K.M., Couldwell W.T. Incidental meningiomas. Neurosurg focus 2011;31(6):E19. https://doi.org/10.3171/2011.9.FOCUS11220
10. Lo W.M., Tohme S.T., Geller D.A. Recent advances in minimally invasive liver resection for colorectal cancer liver metastases – a review. Cancers 2022;15(1):142. https://doi.org/10.3390/cancers15010142
11. Miskovic D., Wexner S.D., Stojadinovic A. et al. Robotic colorectal surgery: Where are we now? Surg Endosc 2021;35(2):389–403. https://doi.org/10.1007/s00464-020-07784-x
12. Husarova T., MacCuaig W.M., Dennahy I.S. et al. Intraoperative imaging in hepatopancreatobiliary surgery. Cancers 2023;15(14):3694. https://doi.org/10.3390/cancers15143694
13. Cai H., Wang Y., Qin D. et al. Advanced surgical technologies for lung cancer treatment: Current status and perspectives. Engineered Regeneration 2023;4(4):55–67. https://doi.org/10.1016/j.engreg.2022.12.001
14. Luengo Morato Y., Ovejero Paredes K., Lozano Chamizo L. et al. Recent advances in multimodal molecular imaging of cancer mediated by hybrid magnetic nanoparticles. Polymers 2021;13(17):2989. https://doi.org/10.3390/polym13172989
15. Sharma P., Jhawat V., Mathur P., Dutt R. Innovation in cancer therapeutics and regulatory perspectives. Med Oncol 2022;39(5):76. https://doi.org/10.1007/s12032-022-01677-0
16. Liu J., He S., Luo Y. et al. Tumor-microenvironment-activatable polymer nano-immunomodulator for precision cancer photoimmunotherapy. Adv Mater 2022;34(8):e2106654. DOI: 10.1002/adma.202106654
17. Yang H., Li C., Xie Q. Advances in the use of nanomaterials in tumour therapy: challenges and prospects. Cancer Insight 2023;2(2):37–48. https://doi.org/10.58567/ci02020004
18. Janjigian Y.Y., Kawazoe A., Yañez P. et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature 2021;600(7890):727–30. https://doi.org/10.1038/s41586-021-04161-3
19. Forde P.M., Chaft J.E., Smith K.N. et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med 2018;378(21):1976–86. https://doi.org/10.1056/NEJMoa1716078
20. Amaria R.N., Reddy S.M., Tawbi H.A. et al. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 2018;24(11):1649–54. https://doi.org/10.1038/s41591-018-0197-1
21. Chow W.B., Ko C.Y., Rosenthal R.A., Esnaola N.F. ACS NSQIP / AGS BEST PRACTICE GUIDELINES: Optimal Preoperative Assessment of the Geriatric Surgical Patient. In ACS NSQIP / AGS BEST PRACTICE GUIDELINES: Optimal Preoperative Assessment of the Geriatric Surgical Patient. 2011.
22. Brodersen F., Wagner J., Uzunoglu F.G., Petersen-Ewert C. Impact of preoperative patient education on postoperative recovery in abdominal surgery: a systematic review. World J Surg 2023;47(4):937–47. https://doi.org/10.1007/s00268-022-06884-4
23. Vaquero Roncero L.M., Sánchez Poveda D., Valdunciel García J.J. Perioperative use of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists. J Clin Anesth 2017;40:91–8. https://doi.org/10.1016/j.jclinane.2017.04.018
24. De Simone B., Sartelli M., Coccolini F. et al. Intraoperative surgical site infection control and prevention: a position paper and future addendum to WSES intra-abdominal infections guidelines. WJES 2020;15(1):10. https://doi.org/10.1186/s13017-020-0288-4
25. Long D.R., Alverdy J.C., Vavilala M.S. Emerging paradigms in the prevention of surgical site infection: the patient microbiome and antimicrobial resistance. Anesthesiology 2022;137(2):252–62. https://doi.org/10.1097/ALN.0000000000004267
26. Rosa R., Sposato K., Abbo L.M. Preventing surgical site infections: implementing strategies throughout the perioperative continuum. AORN 2023;117(5):300–11. https://doi.org/10.1002/aorn.13913
27. Breast Surgery Postoperative Care – Brigham and Women’s Hospital. https://www.brighamandwomens.org/surgery/breastsurgery/post-operative-care#:~:text=At%20Brigham%20and%20Women’s%20Hospital,while%20minimizing%20pain%20and%20complications
28. Dencker E.E., Bonde A., Troelsen A. et al. Postoperative complications: an observational study of trends in the United States from 2012 to 2018. BMC Surgery 2021;21(1). https://doi.org/10.1186/s12893-021-01392-z
29. Morrison-Jones V., West M. Post-operative care of the cancer patient: emphasis on functional recovery, rapid rescue, and survivorship. Curr Oncol 2023;30(9):8575–85. https://doi.org/10.3390/curroncol30090622
30. Zhang X., Li H., Wu F. et al. Neoadjuvant chemotherapy combined with breast-conserving surgery in the treatment of triple-negative breast cancer. J Oncol 2022:7847889. https://doi.org/10.1155/2022/7847889
31. Haverkamp D., Redwood D., Roik E. et al. Elevated colorectal cancer incidence among American Indian/Alaska Native persons in Alaska compared to other populations worldwide. Int J Circumpolar Health 2023;82(1):2184749. https://doi.org/10.1080/22423982.2023.2184749
32. Pearson C., Fraser J., Peake M. et al. Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer. Cancer epidemiology 2019;61:111–8. https://doi.org/10.1016/j.canep.2019.05.010
33. Fry A., White B., Nagarwalla D. et al. Relationship between ethnicity and stage at diagnosis in England: a national analysis of six cancer sites. BMJ Open 2023;13(1):e062079. https://doi.org/10.1136/bmjopen-2022-062079
34. Mitchell M. Cancer in the UK: Overview 2024. Cancer Research UK. 2024.
35. Collins D.C., Sundar R., Lim J.S.J., Yap T.A. Towards precision medicine in the clinic: from biomarker discovery to novel therapeutics. Trends Pharmacol Sci 2017;38(1):25–40. https://doi.org/10.1016/j.tips.2016.10.012
36. Yi M., Zheng X., Niu M. et al. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer 2022;21(1):28. https://doi.org/10.1186/s12943-021-01489-2
37. Cheng F., Su L., Qian C. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget 2016;7(30):48832–41. https://doi.org/10.18632/oncotarget.9453
38. Guo X., Yang X., Wu J. et al. Tumor-treating fields in glioblastomas: past, present, and future. Cancers 2022:14(15):3669. https://doi.org/10.3390/cancers14153669
39. Witmer H.D.D., Dhiman A., Turaga K.K. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand? Cancer 2023;129(4):495–502. https://doi.org/10.1002/cncr.34567
40. Volders J.H., Negenborn V.L., Spronk P.E. et al. Breast-conserving surgery following neoadjuvant therapy – a systematic review on surgical outcomes. Breast cancer research and treatment 2018;168(1):1–12. https://doi.org/10.1007/s10549-017-4598-5
41. Parks R., Cheung K.L. Challenges in geriatric oncology – a surgeon’s perspective. Curr Oncol 2022;29(2):659–74. https://doi.org/10.3390/curroncol29020058
42. Vakili-Ojarood M., Naseri A., Shirinzadeh-Dastgiri A. et al. Ethical Considerations and Equipoise in Cancer Surgery. Indian J Surg Oncol 2024;15(Suppl 3):363–73. https://doi.org/10.1007/s13193-024-02023-8
43. Albrecht B., Alfano S., Keane H., Yang G. Delivering innovation: 2020 oncology market outlook. McKinsey & Company. 2020 https://www.mckinsey.com/industries/life-sciences/our-insights/delivering-innovation-2020-oncology-market-outlook
Рецензия
Просмотров:
385
Послать статью по эл. почте 